Ranbaxy Sues US Regulator Over Revoking Approvals for Nexium, Valcyte Copies

The FDA told Ranbaxy this month that it believed its decisions to grant the company tentative approvals for copies of Nexium and Roche AG's antiviral Valcyte were "in error", after it found that Ranba...

















from NDTV News - Profit http://ift.tt/11nyX63